Jan 1, 2026 · The Journal of Drugs in Dermatology (JDD) is a monthly, peer-reviewed, indexed dermatology journal and online resource.

Feb 23, 2014 · Chaque soir, le JDD vous présente les infos dont vous allez entendre parler le lendemain : l'examen du budget 2026 qui se poursuit ; l'audience de Tyler Robinson, accusé de l'assassinat de ...

Not getting the eJDD? Sign up today for the fastest delivery of timely, peer-reviewed content in a convenient and interactive electronic format.

Sep 22, 2025 · JDD reaches around 13,760 dermatology healthcare professionals and has been recognized as the official partner of the Skin of Color Update (SOCU) and the ODAC Dermatology …

The Journal of Drugs in Dermatology (JDD) continues to be a leading dermatology journal, presenting original articles, award-winning case studies, clinical trial reviews and clearance updates, drugs and …

Founder Perry Robins, MD Editor-in-Chief Deborah S. Sarnoff MD

Nov 30, 2023 · These findings suggest that patients with moderate-to-severe psoriasis treated with deucravacitinib for 12 to 16 weeks had significantly decreased severity of illness and improved …

JDD Spotlight: A Novel Topical Approach for Seborrheic Keratoses? Could a new topical formula change the way we manage seborrheic keratoses? In a pilot study, a unique blend of antioxidants,…

Unlimited full-text access to the Journal of Drugs in Dermatology (JDD) library of archives Original research, review articles, award winning case reports and exclusive editorial content

JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.